Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.405    -0.03 (-1.23%)
Bid:
2.405
Ask:
2.415
Spread: 0.01 (0.416%)
Market Cap: $7.93b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

CIB Interim Separate Condensed June Statements

14 Jul 2020 07:00

RNS Number : 8808S
Commercial Intnl Bank (Egypt) SAE
14 July 2020
 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial International Bank (Egypt) S.A.E.

Separate Condensed Interim Financial Statements

June 30, 2020

Click on, or paste the following link into your web browser, to view the associated PDF document. 

 

 

 

 

http://www.rns-pdf.londonstockexchange.com/rns/8808S_1-2020-7-13.pdf

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate Condensed Interim balance sheet as at June 30, 2020

 

 

 

 

 

 

 

 

 

 

Notes

 

 

Jun. 30, 2020

 

 

 

Dec. 31, 2019

 

 

 

 

EGP Thousands

 

 

 

EGP Thousands

 

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

Cash and balances with central bank

7

 

 

30,421,432

 

 

 

 28,273,962

Due from banks

8

 

 

56,777,751

 

 

 

 28,353,366

Loans and advances to banks, net

10

 

 

883,248

 

 

 

 625,264

Loans and advances to customers, net

11

 

 

119,351,228

 

 

 

 119,321,103

Derivative financial instruments

 

 

 

315,916

 

 

 

 216,383

Investments

 

 

 

 

 

 

 

 

- Financial Assets at Fair Value through P&L

12

 

 

357,304

 

 

 

 418,781

- Financial Assets at Fair value through OCI

12

 

 

84,930,779

 

 

 

89,897,257

-Amortized cost

12

 

 

92,811,350

 

 

 

107,225,613

-Investments in associates and subsidiaries

13

 

 

692,010

 

 

 

63,953

Other assets

 

 

 

8,986,441

 

 

 

 9,747,939

Deferred tax assets (Liabilities)

 

 

 

457,940

 

 

 

 350,339

Property, plant and equipment

14

 

 

2,308,961

 

 

 

 2,202,698

Total assets

 

 

 

398,294,360

 

 

 

 386,696,658

 

 

 

 

 

 

 

 

 

Liabilities and equity

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

Due to banks

15

 

 

12,271,095

 

 

 

 11,810,607

Due to customers

16

 

 

318,944,242

 

 

 

 304,483,655

Derivative financial instruments

 

 

 

340,652

 

 

 

 282,588

Current tax liabilities

 

 

 

2,652,208

 

 

 

 4,639,364

Other liabilities

 

 

 

5,434,030

 

 

 

 8,396,487

Other loans

 

 

 

3,250,254

 

 

 

 3,272,746

Provisions

17

 

 

3,067,002

 

 

 

 2,011,369

Total liabilities

 

 

 

345,959,483

 

 

 

 334,896,816

 

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

 

Issued and paid up capital

 

 

 

14,690,821

 

 

 

14,690,821

Reserves

 

 

 

31,327,194

 

 

 

24,342,314

Reserve for employee stock ownership plan (ESOP)

 

 

 

1,260,111

 

 

 

963,152

Retained earnings *

 

 

 

5,056,751

 

 

 

11,803,555

Total equity

 

 

 

52,334,877

 

 

 

51,799,842

Total liabilities and equity

 

 

 

398,294,360

 

 

 

386,696,658

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

 

 

 

 

 

 

(Review report attached)

 

 

 

 

 

 

 

 

*Including net profit for the current period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hisham Ezz Al-Arab

 

 

 

 

Chairman and Managing Director

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate Condensed Interim income statement for the period ended June 30, 2020

 

 

 

 

 

 

 

 

 

 

 

Note

Jun. 30, 2020

 

 

Jun.30, 2019

 

 

 

EGP Thousands

 

 

EGP Thousands

 

 

 

 

 

 

 

Interest and similar income

 

 

20,922,642

 

 

20,695,803

Interest and similar expense

 

 

(8,445,745)

 

 

(10,691,075)

Net interest income

 

 

12,476,897

 

 

10,004,728

 

 

 

 

 

 

 

Fee and commission income

 

 

1,479,217

 

 

1,647,254

Fee and commission expense

 

 

(493,057)

 

 

(536,140)

Net fee and commission income

 

 

986,160

 

 

1,111,114

 

 

 

 

 

 

 

Dividend income

 

 

25,962

 

 

22,454

Net trading income

 

5

177,231

 

 

379,943

Profits (Losses) on financial investments

 

12

832,005

 

 

19,781

Administrative expenses

 

 

(2,844,898)

 

 

(2,617,257)

Other operating (expenses) income

 

 

(1,847,487)

 

 

(661,079)

Intangible assets amortization

 

 

-

 

 

(65,104)

Impairment release (charges) for credit losses

 

 

(2,259,654)

 

 

(795,124)

 

Profit before income tax

 

 

7,546,216

 

 

7,399,456

 

 

 

 

 

 

 

Income tax expense

 

 

(2,652,208)

 

 

(2,058,736)

Deferred tax assets (Liabilities)

 

 

107,601

 

 

17,300

Net profit for the period

 

 

5,001,609

 

 

5,358,020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share

 

6

3.01

 

 

3.23

Basic

 

 

3.00

 

 

3.21

Diluted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hisham Ezz Al-Arab

 

 

 

 

 

Chairman and Managing Director

 

 

 

 

 

 

 

 

 

 

 

 

 

 

         

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim statement of other Comprehensive Income for the period ended June 30, 2020

 

 

 

Last 6 Months

 

 

Last 6 Months

 

 

 

 

 

 

Jun. 30, 2020

 

 

Jun. 30, 2019

 

 

 

 

 

 

EGP Thousands

 

 

EGP Thousands

 

 

 

 

 

 

 

 

 

 

 

 

 

Net profit for the period

 

 

5,001,609

 

 

5,358,020

 

 

 

 

 

 

 

 

 

 

 

 

 

Net change in fair value of instruments measured at fair value through other comprehensive income

 

 

(1,483,581)

 

 

2,838,861

 

 

 

Expected credit loss for fair value of debt instruments measured at fair value through other comprehensive income

 

 

90,512

 

 

(109,668)

 

 

 

Total other comprehensive income for the period

 

 

3,608,540

 

 

8,087,213

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Cash flows for the period ended June 30, 2020

 

 

 

 

 

 

 

 

Notes

Jun. 30, 2020

 

Jun. 30, 2019

 

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

Cash flow from operating activities

 

 

 

 

 

Profit before income tax

 

7,546,216

 

7,399,456

 

Adjustments to reconcile net profit to net cash provided by operating activities

 

 

 

 

 

Fixed assets depreciation

14

328,251

 

275,052

 

Impairment charge for credit losses (Loans and advances to customers and banks)

 

2,144,988

 

875,635

 

Other provisions charges

17

1,096,888

 

3,140

 

Impairment charge for credit losses (due from banks)

 

24,154

 

29,156

 

Impairment charge for credit losses (financial investments)

 

90,512

 

(109,667)

 

Impairment charge for other assets

 

24,621

 

52,772

 

Exchange revaluation differences for financial assets at fair value through OCI

 

(85,180)

 

886,795

 

Intangible assets amortization

 

-

 

65,104

 

Impairment charge financial assets at fair value through OCI

 

-

 

45,664

 

Exchange differences in financial investments in subsidiary

13

(242)

 

3,020

 

Utilization of other provisions

17

(1,066)

 

1,878

 

Other provisions no longer used

17

(43,200)

 

(126,575)

 

Exchange differences of other provisions

17

3,011

 

(69,724)

 

(Profits) losses from selling property, plant and equipment

 

(94)

 

(1,439)

 

(Profits) losses from selling financial investments

12

(924,720)

 

(65,445)

 

Shares based payments

 

296,959

 

247,998

 

Released (Impairment) charges of investments in associates and subsidiaries

 

14,100

 

-

 

Released (Impairment) charges of FVOCI equity instruments

 

78,615

 

-

 

Operating profits before changes in operating assets and liabilities

 

10,593,813

 

9,512,820

 

 

 

 

 

 

 

Net decrease (increase) in assets and liabilities

 

 

 

 

 

Due from banks

8

(507,846)

 

(25,049,337)

 

Treasury bills and other governmental notes

 

-

 

24,315,394

 

Financial assets at fair value through P&L

12

61,477

 

2,262,513

 

Derivative financial instruments

 

(41,469)

 

(75,592)

 

Loans and advances to banks and customers

10 - 11

(2,430,817)

 

(4,776,117)

 

Other assets

 

925,679

 

1,289,326

 

Due to banks

15

460,488

 

(5,879,606)

 

Due to customers

16

14,460,587

 

20,263,230

 

Income tax obligations paid

 

(4,639,364)

 

(3,625,579)

 

Other liabilities

 

(2,962,457)

 

(1,225,572)

 

Net cash provided from operating activities

 

15,920,091

 

17,011,480

 

 

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

 

Proceeds from investments in associates.

 

750

 

-

 

Payments for investment in subsidiaries.

 

(560,963)

 

-

 

Payment for purchases of property, plant, equipment and branches constructions

 

(625,596)

 

(840,953)

 

Proceeds from selling property, plant and equipment

 

94

 

1,439

 

Proceeds from redemption of financial assets at amortized cost

 

59,360,102

 

33,290,053

 

Payment for purchases of financial assets at amortized cost

 

(44,945,839)

 

(32,633,462)

 

Payment for purchases of financial assets at fair value through OCI

 

(50,506,453)

 

(11,433,512)

 

Proceeds from selling financial assets at fair value through OCI

 

55,237,128

 

5,105,870

 

Net cash used in investing activities

 

17,959,223

 

(6,510,565)

 

 

 

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

 

Increase (decrease) in long term loans

 

(22,492)

 

(230,801)

 

Dividend paid

 

(3,370,464)

 

(2,700,544)

 

Net cash used in (provided from) financing activities

 

(3,392,956)

 

(2,931,345)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalent during the period

 

30,486,358

 

7,569,570

 

Beginning balance of cash and cash equivalent

 

22,895,017

 

34,303,645

 

Cash and cash equivalent at the end of the period

 

53,381,375

 

41,873,215

 

 

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

 

 

Cash and balances with central bank

7

30,421,432

 

24,993,377

 

Due from banks

8

56,818,722

 

66,543,158

 

Treasury bills and other governmental notes

9

27,424,702

 

25,344,096

 

Obligatory reserve balance with CBE

7

(22,905,156)

 

(15,980,212)

 

Due from banks with maturities more than three months

 

(10,266,781)

 

(33,329,274)

 

Treasury bills with maturity more than three months

 

(28,111,544)

 

(25,697,930)

 

Total cash and cash equivalent

 

53,381,375

 

41,873,215

 

 

 

 

 

 

       

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate condensed Interim statement of changes in shareholders' equity for the period ended June 30, 2019

Jun. 30, 2019

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

EGP Thousands

Beginning balance

11,668,326

1,710,293

12,776,215

1,549,445

12,421

(1,860,851)

4,323

9,555,755

738,320

36,154,247

Capital increase

2,917,082

-

(2,917,082)

-

-

-

-

-

-

-

Transferred to reserves

-

477,736

6,375,589

-

1,045

-

-

(6,854,370)

-

-

Dividend paid

-

-

-

-

-

-

-

(2,700,544)

-

(2,700,544)

Net profit for the period

-

-

-

-

-

-

-

5,358,020

-

5,358,020

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

2,838,861

-

-

-

2,838,861

Transferred (from) to bank risk reserve

-

-

-

-

-

-

841

(841)

-

-

ECL for impairment of debt instruments investments

-

-

-

-

-

(109,668)

-

-

-

(109,668)

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

247,998

247,998

Ending balance

14,585,408

2,188,029

16,234,722

1,549,445

13,466

868,342

5,164

5,358,020

986,318

41,788,914

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Separate condensed Interim statement of changes in shareholders' equity for the period ended June 30, 2020

Jun. 30, 2020

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

EGP Thousands

Beginning balance

14,690,821

2,188,029

16,474,429

1,549,445

13,466

4,111,781

5,164

11,803,555

963,152

51,799,842

Capital increase

-

-

-

-

-

-

-

-

-

-

Transferred to reserves

-

590,106

7,840,286

-

1,440

-

-

(8,431,832)

-

-

Dividend paid

-

-

-

-

-

-

-

(3,370,464)

-

(3,370,464)

Net profit for the period

-

-

-

-

-

-

-

5,001,609

-

5,001,609

Transferred from reserve for financial assets at fair value through OCI

-

-

-

-

-

(55,142)

-

55,142

-

-

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

(1,483,581)

-

-

-

(1,483,581)

Transferred (from) to bank risk reserve

-

-

-

-

-

-

1,259

(1,259)

-

-

Release provision for impairment of debt instruments investments

-

-

-

-

-

90,512

-

-

-

90,512

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

296,959

296,959

Ending balance

14,690,821

2,778,135

24,314,715

1,549,445

14,906

2,663,570

6,423

5,056,751

1,260,111

52,334,877

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

                  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR KXLFFBDLZBBX
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.